Natural Killer (NK) Cell Therapy Pipeline Research Report 2024: Comprehensive Insights About 100+ Companies and 185+ Pipeline Drugs
19 avr. 2024 07h35 HE
|
Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Natural Killer (NK) cell therapy - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Natural Killer...
Global Flow Cytometry Markets Analysis/Research Report 2023: Immuno-Oncology Frontier and Liquid Biopsy Combine to Create Enormous Market Demand - Forecasts to 2028
13 janv. 2023 04h58 HE
|
Research and Markets
Dublin, Jan. 13, 2023 (GLOBE NEWSWIRE) -- The "Flow Cytometry Markets: Forecasts by Technology, Product and Application, with Executive and Consultant Guides and Including Customized Forecasting"...
Outlook on the Flow Cytometry Global Market to 2025 - Move to Cell Based Analytics is Driving Growth
27 avr. 2022 05h03 HE
|
Research and Markets
Dublin, April 27, 2022 (GLOBE NEWSWIRE) -- The "Flow Cytometry Global Market to 2025" report has been added to ResearchAndMarkets.com's offering. Flow Cytometry is a mainstay of analytical methods...
Global Flow Cytometry Markets, 2022-2027 by Technology, Product and Application, with Executive and Consultant Guides
04 mars 2022 04h18 HE
|
Research and Markets
Dublin, March 04, 2022 (GLOBE NEWSWIRE) -- The "Flow Cytometry Markets: Forecasts by Technology, Product and Application, with Executive and Consultant Guides and Including Customized Forecasting"...
Global Flow Cytometry Market Report 2021-2025 - Immuno-Oncology Frontier and Liquid Biopsy Combine to Create Enormous Market Demand
24 nov. 2021 04h23 HE
|
Research and Markets
Dublin, Nov. 24, 2021 (GLOBE NEWSWIRE) -- The "Flow Cytometry Markets: Forecasts by Technology, Product and Application, with Executive and Consultant Guides and Including Customized Forecasting -...
Cocrystal Pharma Provides Update on its COVID-19 Antiviral Discovery and Development Programs
03 mai 2021 08h00 HE
|
Cocrystal Pharma, Inc.
BOTHELL, Wash., May 03, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel...
Global Cell-Based Assays Markets, 2020-2025: Growing Preference for Cell-Based Assays in Drug Discovery & Increasing Funding for Cell-Based Research
01 avr. 2021 07h58 HE
|
Research and Markets
Dublin, April 01, 2021 (GLOBE NEWSWIRE) -- The "Cell-Based Assays Market by Product & Service (Reagents, Microplate, Cell Lines, Assay Kits, Instrument & Software, Services), Application...
In-Vitro Toxicology/Toxicity Testing Market Worth $14.4 Billion by 2025, Growing at a CAGR of 9% from 2019- Global Opportunity Analysis and Industry Forecasts by Meticulous Research®
23 juin 2020 13h45 HE
|
Meticulous Market Research Pvt. Ltd.
London, June 23, 2020 (GLOBE NEWSWIRE) -- Safety assessment of substances is essential to determine their toxic implications on humans and the environment. Toxicology studies evaluate the substances...
Cocrystal Pharma Reports 2018 Third Quarter Financial Results and Provides Corporate Update
12 nov. 2018 08h00 HE
|
Cocrystal Pharma, Inc.
BOTHELL, WA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel...